These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 1829077
1. The role of gram-positive therapy in the neutropenic patient. Menichetti F, Del Favero A. J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077 [Abstract] [Full Text] [Related]
2. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies. Menichetti F, Del Favero A, Bucaneve G, Aversa F, Fiorio M. Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052 [Abstract] [Full Text] [Related]
3. Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients. Smith SR, Cheesbrough J, Harding I, Davies JM. Br J Haematol; 1990 Dec; 76 Suppl 2():54-6. PubMed ID: 2149054 [Abstract] [Full Text] [Related]
4. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients. Micozzi A, Venditti M, Amadori S, Pulsoni A, Tirindelli C, Martino P. Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046 [Abstract] [Full Text] [Related]
5. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients. Cony-Makhoul P, Brossard G, Marit G, Pellegrin JL, Texier-Maugein J, Reiffers J. Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050 [Abstract] [Full Text] [Related]
6. Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children. Schaison GS, Decroly FC. J Antimicrob Chemother; 1991 Apr; 27 Suppl B():61-7. PubMed ID: 1829078 [Abstract] [Full Text] [Related]
8. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis. Martino P, Micozzi A, Gentile G, Raccah R, Girmenia C, Mandelli F. Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806 [Abstract] [Full Text] [Related]
9. [The use of teicoplanin in neutropenic patients: values and limits]. Espinouse D, Chomarat M. Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573 [Abstract] [Full Text] [Related]
10. Teicoplanin in combination: role in the management of the febrile neutropenic patient. Davies J. Eur J Haematol Suppl; 1993 Jun; 54():25-8. PubMed ID: 8365462 [Abstract] [Full Text] [Related]
11. The use of aminoglycosides in neutropenic patients. Cometta A, Glauser MP. Schweiz Med Wochenschr Suppl; 1996 Jun; 76():21S-27S. PubMed ID: 8677415 [Abstract] [Full Text] [Related]
12. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. Lemerle S, de La Rocque F, Lamy R, Fremaux A, Bernaudin F, Lobut JB, Reinert P. J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122 [Abstract] [Full Text] [Related]
13. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA. Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513 [Abstract] [Full Text] [Related]
14. Teicoplanin therapy in children: a review. Bassetti D, Cruciani M. Scand J Infect Dis Suppl; 1990 Jan; 72():35-7. PubMed ID: 2151065 [Abstract] [Full Text] [Related]
15. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children. Schaison G, Baruchel A, Arlet G. Br J Haematol; 1990 Dec; 76 Suppl 2():24-6. PubMed ID: 2149047 [Abstract] [Full Text] [Related]
19. Teicoplanin for therapy of gram-positive infections in neutropenic patients. Verhagen C, De Pauw BE. Int J Clin Pharmacol Res; 1987 Dec; 7(6):491-8. PubMed ID: 2964418 [Abstract] [Full Text] [Related]